NCT05243875 - Lupus Education Alliance Program | Crick

Overview

Randomized controlled trial of a COVID-19 behavioral and educational intervention for people with systemic lupus erythematosus (SLE).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

SINGLE

Enrollment

274

Conditions

Systemic Lupus Erythematosus COVID-19

Interventions

LEAP Education + NavigationBEHAVIORAL

COVID education involving providing information about COVID for people with SLE and CDC recommendations for testing, testing options (e.g., pharmacies, doctors' offices, at-home), treatment in the event of a positive COVID result, and current recommendations around vaccination for those with SLE; and (2) navigation, which involves individual tailoring of information about where and how to get tested, and where to get vaccinated, and when appropriate, guiding participants in scheduling testing and vaccination appointments.

LEAP EducationBEHAVIORAL

COVID education involving providing information about COVID for people with SLE and CDC recommendations for testing, testing options (e.g., pharmacies, doctors' offices, at-home), treatment in the event of a positive COVID result, and current recommendations around vaccination for those with SLE.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

18 years or older, ability to understand and speak English, diagnosis of SLE

Locations (1)

Tulane University

New Orleans, Louisiana, United States

Outcomes

Primary Outcomes

Incidence of COVID testing

Participant-reported COVID testing

Time frame: 3 months

Incidence of COVID-19 Vaccination

Participant-reported COVID vaccination

Time frame: 3 months